Montemurro, F., Prat, A., Rossi, V., Valabrega, G., Sperinde, J., Peraldo-Neia, C., . . . Scaltriti, M. (2013). Potential biomarkers of long‐term benefit from single‐agent trastuzumab or lapatinib in HER2‐positive metastatic breast cancer. Mol Oncol.
Styl ChicagoMontemurro, Filippo, et al. "Potential Biomarkers of Long‐term Benefit From Single‐agent Trastuzumab or Lapatinib in HER2‐positive Metastatic Breast Cancer." Mol Oncol 2013.
Citace podle MLAMontemurro, Filippo, et al. "Potential Biomarkers of Long‐term Benefit From Single‐agent Trastuzumab or Lapatinib in HER2‐positive Metastatic Breast Cancer." Mol Oncol 2013.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..